Elżbieta Złowocka-Perłowska | kidney cancer | Best Researcher Award

Dr. Elżbieta Złowocka-Perłowska | kidney cancer | Best Researcher Award

Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University | Poland

PUBLICATION PROFILE

Orcid

Dr. Elżbieta Złowocka-Perłowska⚡🌍

INTRODUCTION 🌟

Dr. Elżbieta Złowocka-Perłowska is a distinguished academic and researcher at the Pomeranian Medical University, specializing in clinical genetics, molecular biology, and hereditary cancers. With over two decades of dedication to the Hereditary Cancer Center at the Department of Genetics and Pathomorphology, she has become an influential figure in medical sciences, particularly focusing on bladder and kidney cancer research. Her work aims to integrate trace element analysis into personalized cancer treatment models, contributing significantly to the field of molecular genetics.

EARLY ACADEMIC PURSUITS 🎓

Dr. Złowocka-Perłowska’s academic journey began with a diploma in Biology from the University of Szczecin in 2002. She then pursued a PhD in Medical Sciences at Pomeranian Medical Academy in Szczecin, where she earned her degree with distinction in 2008. Throughout her early academic years, she demonstrated a deep commitment to the study of genetics and its implications for cancer research.

PROFESSIONAL ENDEAVORS 💼

Since 2002, Dr. Złowocka-Perłowska has been associated with the Hereditary Cancer Center at the Pomeranian Medical University. Her career has evolved from a PhD student to a University Lecturer, Assistant Professor, and National Consultant in Clinical Genetics. She has taught both Polish and English-language courses across various medical and biotechnology programs. Dr. Złowocka-Perłowska’s professional endeavors have led her to direct research projects on cancer diagnostics, utilizing molecular techniques like MLPA, TaqMan, and NGS.

CONTRIBUTIONS AND RESEARCH FOCUS ON kidney cancer🔬

Dr. Złowocka-Perłowska’s research is centered on the study of hereditary cancers, particularly bladder and kidney cancers. Her current research project aims to explore the role of trace elements in cancer prognosis, with a specific focus on blood and serum selenium levels as potential markers for survival. She has conducted extensive studies using molecular genetics techniques and has made significant contributions to the understanding of hereditary cancer genetics. Her scientific work has culminated in 51 publications, four patents (including an international patent), and numerous conference presentations.

IMPACT AND INFLUENCE 🌍

As a recognized leader in the field of hereditary cancer research, Dr. Złowocka-Perłowska has had a profound impact on both medical education and healthcare. Her contributions to clinical studies, research, and the advancement of cancer treatments have been recognized internationally. Through her scientific publications and involvement in research projects, she continues to influence the development of personalized medicine and clinical genetics.

ACADEMIC CITATIONS AND PUBLICATIONS 📚

Dr. Złowocka-Perłowska is the author and co-author of numerous scientific papers published in national and international journals. Her work focuses on hereditary cancers and molecular biology, contributing to the advancement of clinical genetics. With 51 publications to her name, her research is frequently cited by peers in the scientific community. Her papers have been presented at several renowned scientific conferences, establishing her as a thought leader in her field.

HONORS & AWARDS 🏆

Dr. Złowocka-Perłowska has received numerous accolades throughout her career, including the Minister of Health’s Team Award in 2005 and the prestigious “Eminent Scientist of the Year 2009” award from the World Scientist Forum International Awards. She has also been honored with multiple Rector’s Awards for her scientific achievements at Pomeranian Medical University. Other recognitions include certifications for NGS sequencing training and contributions to laboratory medical genetics.

FINAL NOTE ✨

Dr. Złowocka-Perłowska’s work is a testament to the power of academic dedication and scientific inquiry. Her commitment to advancing medical genetics, particularly in the study of hereditary cancers, has significantly shaped the field. Through her research, teaching, and clinical contributions, she continues to inspire future generations of scientists and clinicians.

LEGACY AND FUTURE CONTRIBUTIONS 🔮

Dr. Złowocka-Perłowska’s ongoing research on cancer treatment and prognostic markers positions her as a key figure in the evolution of personalized medicine. With her focus on integrating molecular techniques and trace element analysis, her future contributions will likely continue to revolutionize cancer diagnostics and treatment. She leaves a lasting legacy in the field of medical genetics, with a promising trajectory for further scientific discovery.

TOP NOTES PUBLICATIONS 📚

1. Blood and Serum Copper and Zinc Levels and 10-Year Survival of Patients After Kidney Cancer Diagnosis

  • Authors: Elżbieta Złowocka-Perłowska, Piotr Baszuk, Wojciech Marciniak, Róża Derkacz, Aleksandra Tołoczko-Grabarek, Katarzyna Gołębiewska, Marcin Słojewski, Adam Gołąb, Artur Lemiński, Michał Soczawa, et al.
  • Journal: Nutrients
  • Year: 2025
  • DOI: 10.3390/nu17060944

2. Germline BRCA1 and BRCA2 mutations and the risk of bladder or kidney cancer in Poland

  • Authors: Elżbieta Złowocka-Perłowska, Aleksandra Tołoczko-Grabarek, Steven A. Narod, Jan Lubiński
  • Journal: Hereditary Cancer in Clinical Practice
  • Year: 2022
  • DOI: 10.1186/s13053-022-00220-6

3. Germline HOXB13 mutation p.G84E do not confer an increased bladder or kidney cancer risk in Polish population

  • Authors: Elżbieta Złowocka-Perłowska, Aleksandra Tołoczko-Grabarek, Jan Lubiński
  • Journal: Hereditary Cancer in Clinical Practice
  • Year: 2022
  • DOI: 10.1186/s13053-021-00208-8

4. Recurrent PALB2 mutations and the risk of cancers of bladder or kidney in Polish population

  • Authors: Elżbieta Złowocka-Perłowska, Aleksandra Tołoczko-Grabarek, Jan Lubiński
  • Journal: Hereditary Cancer in Clinical Practice
  • Year: 2021
  • DOI: 10.1186/s13053-020-00161-y

5. Survival of bladder or renal cancer in patients with CHEK2 mutations

  • Authors: Elżbieta Złowocka-Perłowska, Alvaro Galli, Tadeusz Dębniak, Marcin Słojewski, Thierry van de Wetering, Aleksandra Tołoczko-Grabarek, Cezary Cybulski, Rodney J. Scott, Jan Lubiński
  • Journal: PLOS ONE
  • Year: 2021
  • DOI: 10.1371/journal.pone.0257132

 

Yang Jiacai | Cancer Research | Best Researcher Award

Mr. Yang Jiacai | Cancer Research | Best Researcher Award

Institute of Burn Research, State Key Laboratory of Trauma, Burn and Combined Injury, Southwest Hospital, Third Military Medical University, China

 Author Profile 📚

Scopus

Early Academic Pursuits 🎓

Mr. Yang Jiacai began his academic journey with a Master’s degree in Immunology from Shantou University (Guangdong, China) in 2013. His studies initially focused on skin immunology, where he delved into the physiological roles of immune cells such as γδ T cells, macrophages, and fibroblasts in wound healing. His work laid a strong foundation for his later research in skin wound healing mechanisms and the regulation of immune responses during tissue repair.

Professional Endeavors 💼

Currently, Mr. Yang is an experimentalist at the Institute of Burn Research, State Key Laboratory of Trauma, Burn and Combined Injury, Southwest Hospital, Third Military Medical University, Chongqing, China. His research is at the intersection of immunology and wound healing, particularly focusing on the roles of immune cells in skin repair and regeneration. His ongoing projects include a study on scarless wound healing in diabetic wounds and the exploration of DETC functions in burn injuries.

Contributions and Research Focus 🔬

Over the years, Mr. Yang has made significant contributions to the understanding of immune modulation in skin wound healing. His studies on the immune regulatory roles of fibroblast-secreted exosomes and Vγ4+ γδ T cells in macrophage polarization have opened new pathways for potential therapeutic approaches in wound healing. Moreover, his research on the antitumor activity of dendritic epidermal T cells (DETCs) has brought attention to their selective cytotoxicity and potential in cancer immunotherapy.

Impact and Influence 🌍

Mr. Yang’s work has garnered attention in the scientific community, as evidenced by his numerous publications in high-impact journals such as Journal of Investigative Dermatology and iScience. His research has not only contributed to advancing the field of skin wound healing but also provided key insights into immune cell dynamics that could influence cancer immunotherapy. His studies continue to impact both basic research and clinical practices related to burn injuries, wound healing, and tumor immunology.

Academic Cites 📚

Mr. Yang’s research has been widely cited, with several influential papers published in prestigious journals. For instance, his study on the selective cytotoxicity of skin-resident γδ T cells in tumor therapy has recently been published in Journal of Investigative Dermatology (November 2024). Other notable publications include his research on macrophage activation by fibroblast-exosomes in J Invest Dermatol (2025) and on MSCs’ role in angiogenesis in Front Immunol (2022). His work is increasingly recognized for its novel contributions to immunology and wound healing.

Technical Skills 🛠

Mr. Yang is highly skilled in various laboratory techniques related to immunology and skin biology. His expertise includes cellular immunology, flow cytometry, cell culture, wound healing assays, exosome isolation, and molecular biology techniques. Additionally, his proficiency in handling advanced in vitro and in vivo models allows him to investigate the dynamic interactions between immune cells, fibroblasts, and stem cells in skin repair and regeneration.

Teaching Experience 👨‍🏫

Mr. Yang has not listed formal teaching positions, his extensive knowledge and expertise in immunology and wound healing make him a valuable resource for mentorship and training in the lab. His guidance has likely shaped the careers of emerging researchers in the field, and his research collaborations reflect his commitment to knowledge-sharing within the scientific community.

Legacy and Future Contributions 🔮

Mr. Yang’s work has laid the groundwork for future breakthroughs in skin wound healing and cancer immunotherapy. His focus on immune cell dynamics, particularly the roles of γδ T cells and macrophages, promises to transform therapeutic strategies for both burn injuries and tumors. His ongoing research, including scarless wound healing regulation through novel technologies, signals his ongoing contributions to medical innovations. Looking ahead, Mr. Yang’s legacy will continue to inspire future research in immunology and regenerative medicine, with the potential for groundbreaking clinical applications.

 

Top Noted Publications 📖

Orchestration of Macrophage Polarization Dynamics by Fibroblast-Secreted Exosomes during Skin Wound Healing

Authors: Chen, C., Yang, J., Shang, R., Luo, G., He, W.
Journal: Journal of Investigative Dermatology
Year: 2025

Spatiotemporal Orchestration of Macrophage Activation Trajectories by Vγ4 T Cells during Skin Wound Healing

Authors: Hu, W., Zhang, X., Liu, Z., Luo, G., He, W.
Journal: iScience
Year: 2024

Comparison of Inferior Vena Cava Puncture Under Continuous Cardiac Perfusion with Cardiac Puncture in Blood Acquisition of the Laboratory Mouse

Authors: Hu, W., Sheng, H., Yang, J., Huang, C., Luo, G.
Journal: Laboratory Animals
Year: 2024

P311 Promotes IL-4 Receptor‒Mediated M2 Polarization of Macrophages to Enhance Angiogenesis for Efficient Skin Wound Healing

Authors: Chen, C., Tang, Y., Zhu, X., Luo, G., He, W.
Journal: Journal of Investigative Dermatology
Year: 2023

Dendritic Epidermal T Cells Secreting Exosomes Promote the Proliferation of Epidermal Stem Cells to Enhance Wound Re-Epithelialization

Authors: Liu, M., Liu, Z., Chen, Y., Luo, G., He, W.
Journal: Stem Cell Research and Therapy
Year: 2022